Efficacy of 400 mg Efavirenz Versus Standard 600 mg Dose in HIV/TB Co-infected Patients

Clinical trial NCT04513379 · UNKNOWN

Trial details

NCT number: NCT04513379
Sponsor: Shanghai Public Health Clinical Center
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

HIV Infections Tuberculosis

Start date: 2020-11-01
Primary completion: 2022-10-30
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.